|1.||Psaty, Bruce M: 1 article (04/2015)|
|2.||Veeraraghavan, Narayanan: 1 article (04/2015)|
|3.||Wilson, James G: 1 article (04/2015)|
|4.||Wei, Peng: 1 article (04/2015)|
|5.||Yu, Bing: 1 article (04/2015)|
|6.||Gibbs, Richard: 1 article (04/2015)|
|7.||Alexander, Danny: 1 article (04/2015)|
|8.||Dehghan, Abbas: 1 article (04/2015)|
|9.||Musani, Solomon K: 1 article (04/2015)|
|10.||Boerwinkle, Eric: 1 article (04/2015)|
|1.||Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/01/2008 - "We tested the hypothesis that genetic variation in the histidase gene (HAL), which catalyzes the formation of UCA in the skin, modifies risk of basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) in a population-based study (914 BCC, 702 SCC and 848 controls). "
11/01/1975 - "This report presents results of a study on the effects of TPA on epidermal histidase (L-histidine ammonia lyase), an enzyme found in normal epidermis but not in dermis or in mouse squamous cell carcinomas. "
04/01/2015 - "By conducting whole exome sequencing on 1152 African Americans in the Atherosclerosis Risk in Communities (ARIC) study and focusing on loss-of-function (LoF) variants, we identified 3 novel rare LoF variants in HAL, a gene that encodes histidine ammonia-lyase in the first step of histidine catabolism. "
|4.||Schizophrenia (Dementia Praecox)
01/01/1997 - "In the present study, we used a tetranucleotide repeat polymorphism in intron 8 of the histidase gene to examine the possibility that the histidase gene contributes to the genetic component of schizophrenia. "
01/01/1997 - "Association study of schizophrenia and the histidase gene."
01/01/1997 - "We therefore concluded that our results do not support an involvement of the histidase gene in the development of schizophrenia."
01/01/1997 - "Previous findings of increased heterozygosity for histidinemia among schizophrenic patients make the histidase gene a plausible candidate for genetic studies in schizophrenia. "
07/01/1990 - "Experiments were conducted on 182 rats with acute cholestasis to study the effect of intra-abdominal dalargin injection (10 mcg/kg) with the serotonin antagonist ketanserine (150 mg/kg) on xanthine oxidase (XO) activity and level of lipid peroxidation in the hepatic tissue and on the activity of the hepatospecific enzymes histidase and urokaninase in hepatic tissue and blood serum 1, 3, and 5 hours after the injection. "
|2.||Urocanate Hydratase (Urocanase)
|6.||Serotonin (5 Hydroxytryptamine)
|10.||Urokinase-Type Plasminogen Activator (Urokinase)